nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Gadoteridol—Discomfort—Captopril—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Gadoteridol—Paraesthesia—Mometasone—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Gadoteridol—Dry mouth—Captopril—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Gadoteridol—Dyspnoea—Mometasone—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Gadoteridol—Bradycardia—Lisinopril—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Gadoteridol—Anaphylactic shock—Captopril—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Gadoteridol—Rhinitis—Lisinopril—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Gadoteridol—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Gadoteridol—Dysgeusia—Leflunomide—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Gadoteridol—Shock—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Gadoteridol—Pain—Mometasone—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Gadoteridol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Gadoteridol—Malaise—Azathioprine—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Gadoteridol—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Gadoteridol—Hypotension—Captopril—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Gadoteridol—Pruritus—Pentoxifylline—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Gadoteridol—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Gadoteridol—Tinnitus—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Gadoteridol—Flushing—Lisinopril—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Gadoteridol—Malaise—Leflunomide—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Gadoteridol—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Gadoteridol—Tremor—Mycophenolic acid—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Gadoteridol—Body temperature increased—Mometasone—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Gadoteridol—Abdominal pain—Mometasone—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Gadoteridol—Discomfort—Azathioprine—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Gadoteridol—Paraesthesia—Captopril—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Gadoteridol—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Gadoteridol—Dyspnoea—Captopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Gadoteridol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Gadoteridol—Cough—Leflunomide—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Gadoteridol—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Gadoteridol—Dizziness—Pentoxifylline—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Gadoteridol—Hypertension—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Gadoteridol—Malaise—Mycophenolic acid—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Gadoteridol—Erythema—Lisinopril—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Gadoteridol—Syncope—Mycophenolic acid—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Gadoteridol—Chest pain—Leflunomide—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Gadoteridol—Anxiety—Leflunomide—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Gadoteridol—Dysgeusia—Lisinopril—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Gadoteridol—Discomfort—Leflunomide—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Gadoteridol—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Gadoteridol—Dry mouth—Leflunomide—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Gadoteridol—Cough—Mycophenolic acid—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Gadoteridol—Vomiting—Pentoxifylline—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Gadoteridol—Convulsion—Mycophenolic acid—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Gadoteridol—Rash—Pentoxifylline—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Gadoteridol—Hypertension—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Gadoteridol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Gadoteridol—Headache—Pentoxifylline—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Gadoteridol—Face oedema—Prednisone—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Gadoteridol—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Gadoteridol—Feeling abnormal—Captopril—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Gadoteridol—Chest pain—Mycophenolic acid—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Gadoteridol—Anxiety—Mycophenolic acid—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Gadoteridol—Hypotension—Azathioprine—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Gadoteridol—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Gadoteridol—Cardiac arrest—Prednisone—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Gadoteridol—Tremor—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Gadoteridol—Discomfort—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Gadoteridol—Pruritus—Mometasone—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Gadoteridol—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Gadoteridol—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Gadoteridol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Gadoteridol—Abdominal pain—Captopril—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Gadoteridol—Body temperature increased—Captopril—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Gadoteridol—Oedema—Mycophenolic acid—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Gadoteridol—Nausea—Pentoxifylline—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Gadoteridol—Malaise—Lisinopril—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Gadoteridol—Diarrhoea—Mometasone—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Gadoteridol—Syncope—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Gadoteridol—Shock—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Gadoteridol—Hypotension—Leflunomide—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Gadoteridol—Loss of consciousness—Lisinopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Gadoteridol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Gadoteridol—Cough—Lisinopril—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Gadoteridol—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Gadoteridol—Paraesthesia—Leflunomide—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Gadoteridol—Chest pain—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Gadoteridol—Anxiety—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Gadoteridol—Dyspnoea—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Gadoteridol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Gadoteridol—Discomfort—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Gadoteridol—Vomiting—Mometasone—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Gadoteridol—Dry mouth—Lisinopril—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Gadoteridol—Feeling abnormal—Azathioprine—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Gadoteridol—Rash—Mometasone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Gadoteridol—Dermatitis—Mometasone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Gadoteridol—Headache—Mometasone—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Gadoteridol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Gadoteridol—Oedema—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Gadoteridol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Gadoteridol—Pruritus—Captopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Gadoteridol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gadoteridol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gadoteridol—Pain—Leflunomide—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gadoteridol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Gadoteridol—Shock—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Gadoteridol—Body temperature increased—Azathioprine—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Gadoteridol—Abdominal pain—Azathioprine—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Gadoteridol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Gadoteridol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Gadoteridol—Diarrhoea—Captopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Gadoteridol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Gadoteridol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Gadoteridol—Nausea—Mometasone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Gadoteridol—Pain—Mycophenolic acid—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Gadoteridol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Gadoteridol—Cough—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Gadoteridol—Hypotension—Lisinopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Gadoteridol—Dizziness—Captopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Gadoteridol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Gadoteridol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Gadoteridol—Urticaria—Leflunomide—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Gadoteridol—Abdominal pain—Leflunomide—systemic scleroderma	0.002	0.002	CcSEcCtD
Gadoteridol—Body temperature increased—Leflunomide—systemic scleroderma	0.002	0.002	CcSEcCtD
Gadoteridol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Gadoteridol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Gadoteridol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Gadoteridol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Gadoteridol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Gadoteridol—Paraesthesia—Lisinopril—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Gadoteridol—Vomiting—Captopril—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Gadoteridol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Gadoteridol—Dyspnoea—Lisinopril—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Gadoteridol—Rash—Captopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Gadoteridol—Dermatitis—Captopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Gadoteridol—Headache—Captopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Gadoteridol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Gadoteridol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Gadoteridol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Gadoteridol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Gadoteridol—Shock—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Gadoteridol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Gadoteridol—Pain—Lisinopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Gadoteridol—Bradycardia—Prednisone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Gadoteridol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Gadoteridol—Diarrhoea—Azathioprine—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Gadoteridol—Nausea—Captopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Gadoteridol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Gadoteridol—Pruritus—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Gadoteridol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Gadoteridol—Dizziness—Azathioprine—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Gadoteridol—Diarrhoea—Leflunomide—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Gadoteridol—Urticaria—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Gadoteridol—Abdominal pain—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Gadoteridol—Body temperature increased—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Gadoteridol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Gadoteridol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Gadoteridol—Vomiting—Azathioprine—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Gadoteridol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Gadoteridol—Rash—Azathioprine—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Gadoteridol—Dermatitis—Azathioprine—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Gadoteridol—Flushing—Prednisone—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Gadoteridol—Headache—Azathioprine—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Gadoteridol—Dizziness—Leflunomide—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Gadoteridol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Gadoteridol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Gadoteridol—Sweating—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Gadoteridol—Vomiting—Leflunomide—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Gadoteridol—Hypersensitivity—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Gadoteridol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Gadoteridol—Rash—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Gadoteridol—Dermatitis—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Gadoteridol—Nausea—Azathioprine—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Gadoteridol—Headache—Leflunomide—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gadoteridol—Erythema—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gadoteridol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Gadoteridol—Pruritus—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Gadoteridol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Gadoteridol—Rash—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gadoteridol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gadoteridol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Gadoteridol—Headache—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Gadoteridol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Gadoteridol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Gadoteridol—Nausea—Leflunomide—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Gadoteridol—Diarrhoea—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Gadoteridol—Dizziness—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Gadoteridol—Nausea—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Gadoteridol—Malaise—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gadoteridol—Syncope—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Gadoteridol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Gadoteridol—Vomiting—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Gadoteridol—Rash—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Gadoteridol—Convulsion—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Gadoteridol—Dermatitis—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Gadoteridol—Hypertension—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Gadoteridol—Headache—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Gadoteridol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Gadoteridol—Anxiety—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Gadoteridol—Discomfort—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Gadoteridol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Gadoteridol—Nausea—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Gadoteridol—Oedema—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Gadoteridol—Shock—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Gadoteridol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Gadoteridol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Gadoteridol—Rash—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Gadoteridol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Gadoteridol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Gadoteridol—Cough—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gadoteridol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Gadoteridol—Urticaria—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Gadoteridol—Abdominal pain—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Gadoteridol—Body temperature increased—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisone—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Gadoteridol—Pain—Methotrexate—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Gadoteridol—Pruritus—Prednisone—systemic scleroderma	0.000912	0.000912	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Gadoteridol—Diarrhoea—Prednisone—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Gadoteridol—Dizziness—Prednisone—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Gadoteridol—Vomiting—Prednisone—systemic scleroderma	0.00082	0.00082	CcSEcCtD
Gadoteridol—Rash—Prednisone—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Gadoteridol—Dermatitis—Prednisone—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Gadoteridol—Headache—Prednisone—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Gadoteridol—Nausea—Prednisone—systemic scleroderma	0.000766	0.000766	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—systemic scleroderma	0.000737	0.000737	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Gadoteridol—Rash—Methotrexate—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Gadoteridol—Headache—Methotrexate—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
